ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
2
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,113
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
Rapid сommunication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB).
Author(s):
World Health Organization (WHO)
Publication date:
2018
Read this book at
Bookmark
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Annual Reviews Tuberculosis
Data availability:
Comments
Comment on this book
Sign in to comment
Similar content
2,113
Biometry; Sokal RR, Rohlf FJ, editors.
Authors:
RR Sokal
,
FJ Rohlf
Evaluation of the recently reported USP gradient HPLC method for analysis of anti-tuberculosis drugs for its ability to resolve degradation products of rifampicin.
Authors:
Bhavika Mohan
,
Nishi Sharda
,
Saranjit Singh
Micro-analysis of pure deoxyribonucleic acid-dependent ribonucleic acid polymerase from
Escherichia coli
. Action of heparin and rifampicin on structure and function
Authors:
Volker Neuhoff
,
Wolf-Bernhard Schill
,
Hans Sternbach
See all similar
Cited by
1
A Bedaquiline, Pyrazinamide, Levofloxacin, Linezolid, and Clofazimine Second-line Regimen for Tuberculosis Displays Similar Early Bactericidal Activity as the Standard Rifampin-Based First-line Regimen
Authors:
Kayvan Zainabadi
,
Stalz Charles Vilbrun
,
Laurent Daniel Mathurin
…
See all cited by